Rele of MAP kinases in normal and abnormal renal development
Rele of MAP kinases in normal and abnormal renal development
批准号:
10670757
负责人:
AWAZU Midori
金额:
$1.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We investigated the role of mitogen-activated protein kinase (MAPK) family, a critical enzyme in cellular signaling, in normal and abnormal renal development. Extracellular signal-regulated kinase (ERK), p38 MAPK (p38), and MAPK phosphatase-1 (MKP-1) are strongly expressed in the developing kidney, and JNK is detected predominantly in the adult kidney. Both the temporal and spatial expression of ERK coincides with the maturation of the kidney.We next investigated the role of ERK and p38 in organ culture system using ERK or p38 inhibitors. Both ERK and p38 are demonstrated to be necessary for renal development. ERK appears to play a role in nephrogenesis and p38 for kidney growth and nephrogenesis.Next the role of MAPKs in abnormal kidney development was examined. p38 is ectopically expressed, and JNK is downregulated in dysplastic epithelia of human multicystic dysplastic kidney. Furthermore, dysplastic epithelia are exclusively positive for ERK and P-ERK. Activated p38 and ERK may med … More iate hyperproliferation of dysplastic tubules resulting in cyst formation/whereas downregulated JNK expression may be the cause or the result of an undifferentiated state of dysplastic epithelia. The same pattern of MAPK dysregulation was observed in the mouse model of polycystic kidney disease.Fibroblast growth factor 2 (FGF2) prevents apoptosis and stimulates proliferation of metanephric mesenchymal cells (MMCs). The cellular signaling of FGF2 in MMCs has not yet been clarified. We therefore investigated whether p38 and ERK were involved in FGF2-induced mitogenesis and migration of MMCs. Our results showed that both p38 and ERK are activated by FGF2 and mediate FGF2-induced mitogenesis and migration of MMCs.Since dysplastic kidneys are commonly associated with fetal urinary tract obstruction, we investigated the expression-of MAPKs in ovine model of fetal urinary tract obstruction. Similarly to human multicystic dysplastic kidney and mouse polycystic kidney. p38, ERK are upregulated and JNK was downregulated in cyst epithelia and dysplastic tubules.In conclusion, we have demonstrated that MAPKs play an important role in normal and abnormal kidney development. Less
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Awazu M., et al.: "MAP kinase in renal development"Nephrol Dial Transplant. (印刷中). (2002)
Awazu M. 等人:“肾发育中的 MAP 激酶”Nephrol Dial Transplant(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
大森さゆ 他: "腎嚢胞性疾患におけるMAPキナーゼ"発達腎研究会誌. (印刷中). (2002)
Sayu Omori 等人:“肾囊肿病中的 MAP 激酶”,发育肾脏研究学会杂志(2002 年出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
飛彈麻里子 他: "腎発生におけるMAPキナーゼの役割"発達腎研究会誌. (印刷中).
Mariko Hijima 等人:“MAP 激酶在肾脏发育中的作用”,发育肾脏研究学会杂志(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
粟津緑: "Annual Review腎臓2002"Multicystic dysplastic kidney とMAPKSのdysregulation(印刷中). (2002)
Midori Awazu:“2002 年肾脏年度回顾”多囊性发育不良性肾脏和 MAPKS 失调(印刷中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
大森 さゆ 他: "嚢胞性腎疾患におけるMAPキナーゼ"発達腎研究会誌. (印刷中). (2002)
Sayu Omori 等人:“囊性肾病中的 MAP 激酶”,发育肾脏研究学会杂志(正在出版)(2002 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 32 条
DNA methylation and hydroxymethylation in the kidney from offspring of nutrient restricted rats
-
批准号:17K10152
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2017
-
负责人:AWAZU Midori
-
依托单位:
Mechanism of impaired nephrogeneis in intrauterine growth retardation and development of treatment strategies.
-
批准号:23591584
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2011
-
负责人:AWAZU Midori
-
依托单位:
The effects of maternal undernutrition and glucocorticoid on nephrogenesis
-
批准号:20591286
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2008
-
负责人:AWAZU Midori
-
依托单位:
Regeneration of renal epithelial cells from metanephric mesenchymal cells
-
批准号:14570772
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2002
-
负责人:AWAZU Midori
-
依托单位:
国内基金
海外基金
登录
查看更多内容
EGFR/MAPK/ERK信号通路介导肿瘤相关成纤维细胞分泌TNC导致复发/转移头颈部鳞状细胞癌免疫治疗抵抗的机制研究
-
批准号:JCZRLH202600215
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
肠道菌群代谢物5-HTP负调控MAPK/ERK通路改善孤独症样行为的机制研究
-
批准号:JCZRQNB202600954
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于PD-1/PD-L1调控PI3K/AKT与MAPK/ERK通路探讨栀子苷-大黄素配伍改善脓毒症免疫抑制的作用
-
批准号:2026JJ81015
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢伶俐
-
依托单位:
基于PTEN/MAPK/ERK轴的暖巢助孕方干预POI线粒体功能障碍研究
-
批准号:2026JJ81878
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈镇
-
依托单位:
丁酸通过抑制p38/ERK/JNK信号通路重建Treg/Th17平衡缓解艰难梭菌结肠炎的机制研究
-
批准号:2026JJ82452
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:段菊屏
-
依托单位:
基于谱效关系和MAPK/ERK信号的吴茱萸酒制前后配伍当归治疗原发性痛经物质基础和作用机制研究
-
批准号:2026JJ82685
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘叶倩
-
依托单位:
TBC1D32通过抑制ERK活性保护病理性心肌肥厚
-
批准号:JCZRLH202601434
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
circEIF5A通过ERK1/2-DHPS轴介导EIF5A羟腐胺赖氨酸化增强自噬驱动膀胱癌顺铂耐药的机制与干预研究
-
批准号:2026JJ70012
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:符亮民
-
依托单位:
脂肪干细胞外泌体通过稳定ERK通路促进皮肤创面愈合的机制研究
-
批准号:2026JJ81232
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周小龙
-
依托单位:
基于力学微环境探讨ERK/CDK5/P-MIEF1轴阻滞AECII分化在肺纤维化中的作用及机制研究
-
批准号:2026JJ60258
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邵敏
-
依托单位: